Home » Topics » Regulatory

Regulatory
RSS

ARYx describes novel delivery systems for analgesics

July 11, 2003

Use of dopamine D3 agonists in sexual dysfunction

July 11, 2003

FDA approves Infanrix fifth dose indication

July 10, 2003

EMEA approves Pfizer's Genotropin

July 10, 2003

Use of Y5 receptor antagonists in CNS disorders such as depression

July 10, 2003

Japanese launch announced for OxyContin

July 9, 2003

Amgen/Wyeth seek approval for fifth indication for anti-TNF therapy

July 9, 2003

New indication cleared in Europe for Norditropin

July 8, 2003

Emtriva approved by FDA for treatment of HIV

July 7, 2003

Low-dose Prempro launched

July 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...